The new report by EMR titled, ‘Global Cancer Cachexia Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global cancer cachexia market, assessing the market based on its segments like therapeutics, mechanisms of action, distribution channels, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/cancer-cachexia-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): 7%
Rising cases of cancer and cancer cachexia and advancements in current treatment methods are projected to increase the global market for cancer cachexia. The prevalence of cachexia in North America, Japan, and Europe will make these key cancer cachexia markets in the forecast period. The rise in demand for therapy drugs acts as the major factor driving the cancer cachexia market globally. Furthermore, the advent of pipeline medicines and technical advancements in the cancer cachexia market would provide lucrative possibilities to companies in the forecast years. Another major factor driving market expansion is the rising occurrence of cachexia among the geriatric population.
Industry Definition and Major Segments
Cachexia is a severe health issue of several chronic illnesses linked to low quality of life. Cachexia affects 5–15 percent of those with advanced chronic heart failure and 50–80 percent of people with advanced cancer. Many people with chronic obstructive pulmonary disease (COPD), chronic renal disease, and rheumatoid arthritis experience cachexia as they approach the end of their lives. Cachectic syndrome is a significant cause of morbidity and mortality in cancer patients.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/cancer-cachexia-market
By therapeutics, the market is divided into:
- Progestogens
- Corticosteroids
- Combination Therapy
- Others
By mechanism of action, the market is classified into:
- Appetite Stimulators
- Weight Loss Stabilisers
By distribution channel, the market is segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
On the basis of region, the market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Trends
The rise in a number of research and development activities for the identification of therapeutic medications and their high demand among consumers and expanding technical improvements for the treatment of cancer cachexia fuels the cancer cachexia market expansion. The cancer cachexia market is influenced by an increase in investments in cutting-edge drug research that results in novel, sophisticated medicines with a specific mechanism of action and a greater focus on palliative cancer care. Moreover, global population growth, rising healthcare expenditures, improved healthcare infrastructure, and increased awareness all benefit the cancer cachexia market. The presence of a large number of drug manufacturers and the advancing paradigm of care for cancer patients is supporting the growth of the market globally.
Key Market Players
The major players in the market are Merck & Co., Inc., Aphios Corporation, Helsinn Healthcare SA, AVEO Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., and Pfizer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Media Contact
Company Name: EMR Inc.
Contact Person:- Shira Ellis, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com
Also, Check Procurement Intelligence which provides you Infallible research solutions.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
0 Comments:
Post a Comment